News & Updates — Webinar

Medicaid is the largest payer of opioid use disorder (OUD) treatment in the United States, covering an estimated 40% of adults under the age of 65 with OUD, and plays additional roles in supporting recovery services by funding peer recovery coaches and health-related social needs, and prevention initiatives such as school-based health services. With a wide range of new Medicaid policies now under discussion at the national level, proposed changes have the potential to significantly impact access to OUD treatment and related services which have contributed to a nearly 25% decline in fatal overdoses in the past year.

FORE grantees are on the frontlines studying the various roles Medicaid plays in preventing, treating, and recovering from OUD, as well as reducing overdose deaths. Manatt Health has highlighted ways states can leverage existing authorities under Medicaid and the Children’s Health Insurance Program (CHIP) to sustain innovative prevention programs that support and treat children and families impacted by OUD. The RAND Corporation is assessing how Medicaid dis-enrollments (or “unwinding”) at the end of COVID-19 public health emergency affected access to buprenorphine treatment for at-risk populations, which could provide important lessons. The Legal Action Center engages with the Centers for Medicare & Medicaid Services and tracks 1115 demonstration waivers and policies related to Medicaid enrollment during and after incarceration. And lastly, the National Academy for State Health Policy has been closely engaging with state executive branch officials to learn about their funding priorities and concerns.

Please join us on Wednesday, March 26^th at 2pm EST as we welcome…

• Jocelyn Guyer, MPP, Senior Managing Director
  Manatt Health
  Issue Brief: Funding Pathways for Programs Supporting Families Affected by Substance Use Disorders
• Bradley Stein, MD, PhD, Director of the Opioid Policies, Tools, and Information Center (OPTIC)
  Grantee: RAND Corporation
  Project: Association of State Policies for Unwinding Medicaid’s Continuous Enrollment Provision with Changes in Buprenorphine Treatment
  
• Gabrielle de la Guéronnière, JD, Vice President of Health & Justice Policy
  Grantee: Legal Action Center
  Project: Using Medicaid to Disrupt Cycles of Chronic Illness and Incarceration
  
• Katie Greene, MPP, Director of Public Health
  Grantee: National Academy for State Health Policy (NASHP)
  Project: Strengthening State-Level Prevention, Treatment, Recovery, and Harm Reduction Infrastructure to Address the Opioid and Substance Use Crisis

… as they discuss the most recent data on the vital role of Medicaid in preventing overdose deaths,  proposed changes to Medicaid programs, and their potential impact on the U.S. opioid and overdose crisis.

The webinar will run until 3:30pm to allow for an extended discussion and Q&A session following the presentation.

Register for the Webinar Here

We invite you to look at our Resources page for the most up-to-date information and guidance. You can view a recording of our previous webinars below. As always, please reach out with questions and/or resources that you believe would benefits others.